<DOC>
	<DOCNO>NCT01450293</DOCNO>
	<brief_summary>Infants malaria-endemic region Africa important target vaccination malaria view enormous disease burden malaria population . The purpose trial ass safety immunogenicity MVA ME-TRAP AdCH63 ME-TRAP candidate vaccine healthy child malaria endemic region . The regimen propose protected non-immune volunteer Oxford sporozoite challenge , may protective naturally acquire infection Gambia . Administration AdCh63 ME-TRAP MVA ME-TRAP infant study occur interval least two week administration routine infant immunisation , give accord Gambian EPI .</brief_summary>
	<brief_title>AdCh63 ME-TRAP MVA ME-TRAP Malaria Vaccines Evaluation Healthy Children Malaria Endemic Area</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant age 10 week 512 month time enrollment consent parent . Clinically significant history skin disorder ( psoriasis , contact dermatitis etc . ) , allergy , symptomatic immunodeficiency , cardiovascular disease , respiratory disease , endocrine disorder , liver disease , renal disease , gastrointestinal disease , neurological illness . Severe malnutrition . History allergic disease reaction likely exacerbate component vaccine , e.g . egg product , Kathon , neomycin , betapropiolactone . History splenectomy Haemoglobin le 8.0 g/dL , judge clinically significant opinion investigator Serum Creatinine concentration great 70 mol/L , judge clinically significant opinion investigator Serum ALT concentration great 45 U/L , judge clinically significant opinion investigator Blood transfusion within one month enrollment . History vaccination previous experimental malaria vaccine . Administration vaccine immunoglobulin less two week vaccination IMPs Current participation another clinical trial , within 12 week study . Any finding opinion investigator would increase risk adverse outcome participation trial . Likelihood travel away study area Maternal HIV infection Positive malaria antigen test screening Failure receive , prior enrollment , routine EPI vaccination due accord Gambian EPI schedule .</criteria>
	<gender>All</gender>
	<minimum_age>10 Weeks</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Immune response</keyword>
</DOC>